Clinical Trial Update: Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating angiotensin II for perioperative management of hypotension in kidney transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Kidney Transplant Complications
• Shock

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Shock, Surgical, Shock | Phase 4 | Status: COMPLETED | Results posted: 2022-12-21